Company Overview and News

 
Azumah Resources poised to expand 2.1 million ounce gold bounty and transition to producer

2018-04-20 proactiveinvestors.com.au
Azumah Resources Limited (ASX:AZM) appears substantially undervalued compared with other gold explorers and developers on an enterprise value to resource ounce basis.
Upvote Downvote

 
Azumah Resources flags capital raising as it looks to grow reserves at gold project in Ghana

2018-04-20 proactiveinvestors.com.au
Azumah Resources Limited (ASX:AZM), owner of the Wa Gold Project, has entered a trading halt ahead of releasing details regarding a capital raising.
Upvote Downvote

 
Azumah Resources reaffirms gold drilling success at Butele North target in Ghana

2018-03-21 proactiveinvestors.com.au
Azumah Resources Ltd (ASX:AZM) has revealed a cross-section of its first-pass drilling result of 16 metres at 1.07 g/t gold from surface (including 6 metres at 1.86 g/t gold) at the Butele North target.
Upvote Downvote

 
Azumah Resources hits gold at new Butele North target in Ghana

2018-03-18 proactiveinvestors.com.au
Azumah Resources Ltd (ASX:AZM) has drilled out gold in its first pass drill program at the Butele North target within the Wa Gold Project in Ghana.
Upvote Downvote

 
Azumah Resources extends gold zones at Wa project in Ghana

2018-03-06 proactiveinvestors.com.au
Azumah Resources Limited (ASX:AZM) has extended and better defined zones prospective for gold mineralisation at its Wa project in Ghana.
Upvote Downvote

 
Azumah Resources begins drilling to expand gold reserves in Ghana

2018-03-01 proactiveinvestors.com.au
Azumah Resources Ltd (ASX:AZM) has commenced a 4,500-metre drilling program designed to extend the ore reserves at the flagship Kunche and Bepkong deposits at its Wa Gold Project in Ghana.
Upvote Downvote

 
Azumah Resources aims to grow gold resource with drilling program

2018-01-23 proactiveinvestors.com.au
Azumah Resources Limited’s (ASX:AZM) 940-hole drilling program at its Wa Gold Project in Ghana has prompted the company to undertake further exploration.
Upvote Downvote

 
Azumah Resources Gold Bounty in Ghana

2018-01-11 proactiveinvestors.com.au
Azumah Resources (ASX:AZM) has launched multiple drilling campaigns to expand its gold resources/reserves at the Wa Gold Project in Ghana. MD Stephen Stone brings Proactive up to date on the size of the gold reserve and indeed how the project is funded. The company has delineated a resource of 2.1 million ounces of gold grading 1.5 g/t, which includes 1.4 million ounces in the measured and indicated category grading 1.
Upvote Downvote

 
Azumah Resources establishes strategy to grow 2 million ounce gold bounty

2018-01-08 proactiveinvestors.com.au
Azumah Resources (ASX:AZM) has launched multiple drilling campaigns as it seeks to expand gold resources and reserves at the Wa Gold Project in Ghana.
Upvote Downvote

 
Azumah Resources MD Steve Stone discusses recent ‘game changer’ private equity investment

2017-11-30 proactiveinvestors.com.au
Steve Stone, managing director of Azumah Resources Ltd (ASX:AZM), updates investors at Mines and Money 2017 in London.
Upvote Downvote

 
Azumah Resources receives approval for $17M Ghana gold farm-in

2017-10-27 proactiveinvestors.com.au
Azumah Resources (ASX:AZM) has received consent from the Ghana Minister of Lands and Natural Resources for its $17 million earn-in agreement at the Wa Gold Project in Ghana.
Upvote Downvote

 
Azumah Resources lays plans to advance Wa Gold Project in Ghana

2017-09-20 proactiveinvestors.com.au
Azumah Resources Ltd (ASX:AZM) is now firmly positioned to move into its next phase of growth focused on rapidly advancing its Wa Gold Project in Ghana.
Upvote Downvote

 
Azumah Resources readies raising for Wa Gold Project in Ghana

2017-08-11 proactiveinvestors.com.au
Azumah Resources (ASX:AZM) is progressing towards raising circa $2.3 million through a 1:5 non-renounceable rights issue, which is to be fully underwritten by Perth broker, Patersons Securities.
Upvote Downvote

 
Azumah Resources outlines fully underwritten rights issue

2017-08-04 proactiveinvestors.com.au
Azumah Resources (ASX:AZM) will raise circa $2.3 million through a 1:5 non-renounceable rights issue, which is to be fully underwritten by Perth broker, Patersons Securities.
Upvote Downvote

 
Azumah Resources' Stephen Stone reveals details on a A$17 million earn-in deal

2017-08-02 proactiveinvestors.com.au
The company has revealed details of a deal that will boost gold resources and reserves and deliver a fundable development gold project.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...